Funds holding PLUS THERAPEUTICS INC
ISIN US72941H5090 · United States · LEI 549300XD2PHUC73HMY31
- Fund holders
- 1
- Of which ETFs
- 0 1 other fund
- Value held
- ≈ 58.5K $ 49.8K €
A single tracked fund declares this company. So these figures do not say who owns it.
This issuer has other securities: PLUS THERAPEUTICS INC (US72941H8060)
| Fund | Shares | Value | Weight in fund | |
|---|---|---|---|---|
| ABANTE QUANT VALUE, F.I. ABANTE ASESORES GESTION, SGIIC, S.A. | 49.8K € | 0.27 % | as of Dec 31, 2025 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| ABANTE QUANT VALUE, F.I. ABANTE ASESORES GESTION, SGIIC, S.A. | 0.27 % | as of Dec 31, 2025 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 6 | +1 | 3,670,615 | +56.4 % |
| 2026Q1 | 5 | 0 | 2,347,338 | +123.1 % |
| 2025Q4 | 5 | +1 | 1,052,146 | +1,201.4 % |
| 2025Q3 | 4 | -1 | 80,847 | -9.4 % |
| 2025Q2 | 5 | 0 | 89,250 | -1.1 % |
| 2025Q1 | 5 | +1 | 90,273 | +16.1 % |
| 2024Q4 | 4 | 0 | 77,752 | +27.7 % |
| 2024Q3 | 4 | 0 | 60,888 | -0.2 % |
| 2024Q2 | 4 | 0 | 61,028 | +4.5 % |
| 2024Q1 | 4 | 0 | 58,384 | +80.1 % |
| 2023Q4 | 4 | 32,414 |
Institutional managers
19 managers declare this company to the SEC (Form 13F).
| Manager | Shares | Value | |
|---|---|---|---|
| GEODE CAPITAL MANAGEMENT, LLC | 2,016,314 | 328K $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 1,776,372 | 288.8K $ | as of Mar 31, 2026 |
| STATE STREET CORP | 468,893 | 76.2K $ | as of Mar 31, 2026 |
| NORTHERN TRUST CORP | 293,300 | 47.7K $ | as of Mar 31, 2026 |
| MILLENNIUM MANAGEMENT LLC | 271,599 | 44.2K $ | as of Mar 31, 2026 |
| TWO SIGMA SECURITIES, LLC | 142,812 | 23.2K $ | as of Mar 31, 2026 |
| XTX Topco Ltd | 116,023 | 18.9K $ | as of Mar 31, 2026 |
| CITIGROUP INC | 93,002 | 15.1K $ | as of Mar 31, 2026 |
| UBS Group AG | 87,850 | 14.3K $ | as of Mar 31, 2026 |
| MERCER GLOBAL ADVISORS INC /ADV | 64,112 | 10.4K $ | as of Mar 31, 2026 |
| Miller Financial Services LLC | 50,000 | 8.1K $ | as of Mar 31, 2026 |
| Ashton Thomas Private Wealth, LLC | 32,913 | 5.4K $ | as of Mar 31, 2026 |
| DAGCO, INC. | 25,882 | 4.2K $ | as of Mar 31, 2026 |
| Kestra Advisory Services, LLC | 25,800 | 4.2K $ | as of Mar 31, 2026 |
| Cambridge Investment Research Advisors, Inc. | 13,450 | 2 $ | as of Mar 31, 2026 |
| Forum Financial Management, LP | 10,000 | 1.6K $ | as of Mar 31, 2026 |
| OSAIC HOLDINGS, INC. | 133 | 21 $ | as of Mar 31, 2026 |
| WELLS FARGO & COMPANY/MN | 53 | 9 $ | as of Mar 31, 2026 |
| Sound Income Strategies, LLC | 28 | 4 $ | as of Mar 31, 2026 |
Cite this page
Titelia. "Funds holding PLUS THERAPEUTICS INC". https://titelia.com/en/stocks/plus-therapeutics-inc-US72941H5090